Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Aspen Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (212)
ARTG (8)
Australian public assessment report (AusPar) (2)
Cancellation or suspension (2)
Prescription medicine registration (2)

Date

2024 (6)
2023 (2)
2022 (9)
2020 (11)
2019 (12)
2018 (11)
2017 (92)
2016 (35)
2015 (45)
2014 (2)
2007 (1)

Search

Sponsor content

226 result(s) found, displaying 31 to 40

CYPROCUR 50 cyproterone acetate 50mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 February 2020

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
ASPECILLIN VK phenoxymethylpenicillin 250mg (as potassium) capsule bottle Cancelled under Section 30(1)(c) of the Act

2 October 2019

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
ASPECILLIN V Phenoxymethylpenicillin (as Benzathine) 250mg/5mL oral liquid suspension bottle Cancelled under Section 30(1)(c) of the Act

2 October 2019

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
ASPECILLIN V Phenoxymethylpenicillin (as Benzathine) 125mg/5mL oral liquid, suspension bottle Cancelled under Section 30(1)(c) of the Act

2 October 2019

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
CILAMOX amoxicillin 250mg (as trihydrate) capsule blister pack Cancelled under Section 30(1)(c) of the Act

2 October 2019

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
CILAMOX amoxicillin 500mg (as trihydrate) capsule blister pack Cancelled under Section 30(1)(c) of the Act

2 October 2019

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
TYRAQUES colestyramine 850 mg/g powder sachet Cancelled under Section 30(1)(c) of the Act

2 August 2019

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
MEGACE megestrol acetate 160mg tablet bottle Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
NYOGEL timolol 1mg/g (as maleate) eye gel bottle Cancelled under Section 30(1) (c) of the Act

29 May 2019

Cancellation by sponsor

Requested by Aspen Pharma Pty Ltd
Aspen Pharma Pty Ltd - Dressing, dental, periodontal (277154)

29 June 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Aspen Pharma Pty Ltd - Dressing, dental, periodontal.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.